Elutia Inc Stock Today
| ELUT Stock | 3.22 0.02 0.63% |
PerformanceVery Weak
| Odds Of DistressVery High
|
Elutia is selling for under 3.22 as of the 26th of February 2025; that is 0.63% up since the beginning of the trading day. The stock's last reported lowest price was 3.1. Elutia has a very high chance of experiencing financial distress in the next few years of operation. It has also generated negative returns for investors over the last 90 days. The performance scores are derived for the period starting the 1st of June 2024 and ending today, the 26th of February 2025. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 7th of September 2023 | Category Healthcare | Classification Health Care |
Elutia is entity of United States. It is traded as Stock on NASDAQ exchange. The company has 35.77 M outstanding shares of which 59.36 K shares are currently shorted by private and institutional investors with about 1.93 trading days to cover. More on Elutia Inc
Moving against Elutia Stock
Elutia Stock Highlights
ESG Sustainability
Environmental | Governance | Social |
| Executive Chairman | MS MBA | ||||
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Composite, NASDAQ Health Care, Health Care, Biotechnology, Medical Devices, Healthcare (View all Sectors) | ||||
| Average Analyst Recommendation | |||||
Elutia can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Elutia's financial leverage. It provides some insight into what part of Elutia's total assets is financed by creditors.
| |||||
Elutia Inc (ELUT) is traded on NASDAQ Exchange in USA. It is located in 12510 Prosperity Drive, Silver Spring, MD, United States, 20904 and employs 54 people. Elutia is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a current market capitalization of 129.06 M. Elutia Inc conducts business under Biotechnology sector and is part of Health Care industry. The entity has 35.77 M outstanding shares of which 59.36 K shares are currently shorted by private and institutional investors with about 1.93 trading days to cover.
Elutia generates negative cash flow from operations
Check Elutia Probability Of Bankruptcy
Ownership AllocationElutia holds a total of 35.77 Million outstanding shares. Over half of Elutia's outstanding shares are owned by other corporate entities. These other corporate entities are typically referred to as corporate investors that obtain positions in a given instrument to benefit from reduced trade commissions. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Elutia Ownership Details
Elutia Historical Income Statement
Elutia Stock Against Markets
Elutia Corporate Management
| Erica Elchin | Vice Operations | Profile | |
| Matthew Ferguson | Chief Officer | Profile | |
| Michelle Williams | Chief Officer | Profile | |
| Jeffry Hamet | Treasurer Finance | Profile | |
| Sonali Fonseca | Head Businesses | Profile |
Additional Tools for Elutia Stock Analysis
When running Elutia's price analysis, check to measure Elutia's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Elutia is operating at the current time. Most of Elutia's value examination focuses on studying past and present price action to predict the probability of Elutia's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Elutia's price. Additionally, you may evaluate how the addition of Elutia to your portfolios can decrease your overall portfolio volatility.